Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories

Page 3

TScan examines $100m IPO possibilities
Harvard's T-cell cancer therapy developer has filed to list on the Nasdaq Global Market.
Sense picks up $50m
First reported late last year, Sense Biodetection has confirmed a $50m series B round backed by Cambridge Innovation Capital.
Oatly to milk public markets for capital
The oat milk brand, which has filed for a $100m offering in the US, traces its origins back to Lund University in the 1990s.
SES seeks out corporates to raise $139m
General Motors led a series D round for the lithium-metal battery technology spinout of MIT formerly known as SolidEnergy Systems.
Talaris tries out public markets
University of Louisville spinout Talaris has filed for an initial public offering on the Nasdaq Global Market.
Daily deal net: April 20, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Gyroscope gees itself up for US IPO
The CIC-backed eye disease treatment developer has filed for a $100m initial public offering, having raised over $250m in funding in the past two years.
Lumicks leverages series D investors
Lumicks, which is developing single-molecule analysis technology based on research at Vrije Universiteit Amsterdam, has collected $93m.
Tectonic shifts $80m into series A
Tectonic Therapeutic is the latest venture undertaken by Harvard’s serial entrepreneur Timothy Springer, who co-led the series A round.
Alchemab accesses $82m series A
Alchemab Therapeutics has raised $80m to advance research originating at University of Oxford, Johns Hopkins University and Mount Sinai Hospital.

test reg